Factors associated with the prescription of antidepressive medication to breast cancer patients

Acta Oncologica

Volumn 50, Issue 2, 2011, Pages 243-251

  Suppli, Nis P ^a   Deltour, Isabelle ^a   Damkjær, Lars H ^a   Christensen, Jane ^a   Jensen, Anders B ^b   Kroman, Niels T ^c   Johansen, Christoffer ^a,d   Dalton, Susanne O ^a  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER REHABILITATION; COMORBIDITY; CONTROLLED STUDY; DENMARK; DEPRESSION; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; PRESCRIPTION; PRIORITY JOURNAL; SOCIOECONOMICS; UNEMPLOYMENT;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; BREAST NEOPLASMS; CARCINOMA; COHORT STUDIES; DEPRESSION; FEMALE; HUMANS; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS; REGISTRIES; RISK FACTORS;

EID: 78651517794     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2010.531049     Document Type: Article

References (25)

1. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 2004;6:229-39.
2. Rowland JH, Hewitt M, Ganz PA. Cancer survivorship: A new challenge in delivering quality cancer care. J Clin Oncol 2006;24:5101-4.
3. Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, McGregor BA, et al. Major depression after breast cancer: A review of epidemiology and treatment. Gen Hosp Psychiatry 2008;30:112-26.
4. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: A meta-analysis. Cancer 2009;115:5349-61.
5. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: Metaanalysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101-7.
6. Fallowfi eld L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 2001;84:1011-5.
7. Sharpe M, Strong V, Allen K, Rush R, Postma K, Tulloh A, et al. Major depression in outpatients attending a regional cancer centre: Screening and unmet treatment needs. Br J Cancer 2004;90:314-20.
8. Christensen S, Zachariae R, Jensen AB, Vaeth M, Mø l ler S, Ravnsbaek J, et al. Prevalence and risk of depressive symptoms 3-4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer. Breast Cancer Res Treat 2009;113:339-55.
9. Kim SH, Son BH, Hwang SY, Han W, Yang JH, Lee S, et al. Fatigue and depression in disease-free breast cancer survivors: Prevalence, correlates, and association with quality of life. J Pain Symptom Manage 2008;35:644-55.
10. Bardwell WA, Natarajan L, Dimsdale JE, Rock CL, Mortimer JE, Hollenbach K, et al. Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer. J Clin Oncol 2006;24:2420-7.
11. Osborne RH, Elsworth GR, Hopper JL. Age-specifi c norms and determinants of anxiety and depression in 731 women with breast cancer recruited through a population-based cancer registry. Eur J Cancer 2003;39:755-62.
12. Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: Five year observational cohort study. BMJ 2005;330:702.
13. Azzone V, Frank RG, Pakes JR, Earle CC, Hassett MJ. Behavioral health services for women who have breast cancer. J Clin Oncol 2009;27:706-12.
14. Ashbury FD, Madlensky L, Raich P, Thompson M, Whitney G, Hotz K, et al. Antidepressant prescribing in community cancer care. Support Care Cancer 2003;11:278-85.
15. Gardarsdottir H, Heerdink ER, van DL, Egberts AC. Indications for antidepressant drug prescribing in general practice in the Netherlands. J Affect Disord 2007;98:109-15.
16. Petty DR, House A, Knapp P, Raynor T, Zermansky A. Prevalence, duration and indications for prescribing of antidepressants in primary care. Age Ageing 2006;35:523-6.
17. Hoybye MT, Dalton SO, Christensen J, Larsen LR, Kuhn KG, Jensen JN, et al. Research in Danish cancer rehabilitation: Social characteristics and late effects of cancer among participants in the FOCARE research project. Acta Oncol 2008;47:47-55.
18. Moller S, Jensen MB, Ejlertsen B, Bjerre KD, Larsen M, Hansen HB, et al. The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncol 2008;47:506-24.
19. Thygesen L. The register-based system of demographic and social statistics in Denmark. Stat J UN Econ Comm Eur 1995;12:49-55.
20. Nickelsen TN. Data validity and coverage in the Danish National Health Registry. A literature review. Ugeskr Laeger 2001;164:33-7. Danish.
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40: 373-83.
22. Gaist D, Sorensen HT, Hallas J. The Danish prescription registries. Dan Med Bull 1997;44:445-8.
23. Boudreau DM, Daling JR, Malone KE, Gardner JS, Blough DK, Heckbert SR. A validation study of patient interviewdata and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. Am J Epidemiol 2004;159:308-17.
24. Loprinzi CL, Wolf SL, Barton DL, Laack NN. Symptom management in premenopausal patients with breast cancer. Lancet Oncol 2008;9:993-1001.
25. The Danish National Board of Health. [Internet]. Copenhagen (Denmark): Sundhedsstyrelsen; Kr æ ftprofi l - Brystkr æ ft 2000 - 2007 [cited 2010 Mar]. Available from: .